IMMUNOREACT 13: immune features of healthy rectal mucosa as predictors of invasion risk in stage II rectal cancer
Giorgio Rivella(University of Padua), Michele Antoniutti(Ca' Foncello Hospital), Francesca Galuppini(University of Padua), Chiara Cipollari(La Salle University), Ivana Cataldo(Ospedale SS. Annunziata), Melania Scarpa(University of Padua), Cesare Ruffolo(Ca' Foncello Hospital), Astghik Stepanyan(University of Padua), Marco Massani(AULSS 2 Marca Trevigiana), Stefano Brignola(University of Padua), Tommaso Stecca(Ca' Foncello Hospital), Antonio Scapinello(Istituto Oncologico Veneto), Matteo Fassan(University of Padua), Mario Gruppo(Istituto Oncologico Veneto), Francesco Cavallin, Licia Laurino(University of Padua), Antonella D’Angelo(University of Padua), Andromachi Kotsafti(Istituto Oncologico Veneto), Lavinia Ceccarini(Ospedale San Bassiano), Carlotta Ceccon(University of Padua), Luca Facci(University of Padua), Giovanni Pirozzolo(Ottawa Hospital), Boris Franzato(Istituto Oncologico Veneto), E. Urso, Chiara Vignotto(University of Padua), Gaia Tussardi(Azienda Ospedale - Università Padova), Vincenza Guzzardo(University of Padua), Valerio Pellegrini(University of Padua), Anna Matteazzi(Azienda Ospedale - Università Padova), Luca Saadeh, Anna Pozza(AULSS 2 Marca Trevigiana), Alfonso Recordare(Ospedale dell' Angelo), Matteo Zuin, Ignazio Castagliuolo(University of Padua), Imerio Angriman, Luca Dal Santo, Giuseppe Portale, Isacco Maretto, Gaya Spolverato, Riccardo Quoc Bao, Pierluigi Pilati, Antonio Rosato, IMMUNOREACT Study Group, Ottavia De Simoni, Marco Scarpa(University of Padua), Francesco Marchegiani, Silvia Negro, Roberta Salmaso
Cited by 0
Related Papers
Patient-derived organoids model treatment response of metastatic gastrointestinal cancers
|Science|2018|2.1k
Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas
|Nature Genetics|2013|709
A MicroRNA Targeting Dicer for Metastasis Control
|Cell|2010|665
Evolution of HER2-low expression from primary to recurrent breast cancer
|npj Breast Cancer|2021|226
Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma
|Journal of Hepatology|2018|191